Combination Therapy for Myopia Control

For children with rapidly progressing myopia, combining treatments may provide better control than single therapy alone.

Why Combine Treatments?

Some children experience:

• Rapid progression despite treatment
• Inadequate response to single therapy
• High myopia requiring aggressive management
• Strong family history of high myopia

Common Combinations

Ortho-K + Low-Dose Atropine

• Most studied combination
• May provide additive benefit
• Atropine addresses mechanisms Ortho-K doesn't

MiSight + Atropine

• Combines optical and pharmaceutical approaches
• Emerging research supports efficacy
• May be useful for fast progressors

Specialty Glasses + Atropine

• Good for younger children
• Non-invasive optical correction
• Pharmaceutical support for control

Research Evidence

Studies on combination therapy show:

• Potentially greater efficacy than monotherapy
• Generally well-tolerated
• May allow lower atropine concentrations
• More research needed for optimal protocols

Considerations

• Increased cost and complexity
• More frequent monitoring needed
• Must weigh benefits vs. burden
• Individualized approach essential

When to Consider Combination Therapy

• Progression >0.75D per year on single treatment
• Axial length increasing >0.3mm per year
• High myopia (>-6.00D) at young age
• Strong family history of pathological myopia